CapsoVision, Inc. (CV) Financials

CV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 25.9 million 5.7 million
Dec. 31, 2025 18.2 million 4.9 million
Sept. 30, 2025 25.7 million 5.2 million
June 30, 2025 9.5 million 148.5 million

CV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -6.1 million 334000
Dec. 31, 2025 -12.7 million 349000
Sept. 30, 2025 -5.7 million 307000
June 30, 2025 -4.6 million 170000

CV Net Income

No data available :(

CV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 17.9 million 362000 788000
Dec. 31, 2025 10.1 million 477000 887000
Sept. 30, 2025 17.8 million 584000 978000
June 30, 2025 1.1 million - 1.1 million

CV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 47.5 million
Dec. 31, 2025 245.6 million
Sept. 30, 2025 46.2 million
June 30, 2025 46.3 million

CV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 48000 4.4 million 4.0 million 2.1 million
Dec. 31, 2025 48000 8.8 million 3.7 million 1.9 million
Sept. 30, 2025 12000 6.1 million 3.8 million 1.8 million
June 30, 2025 30000 3.4 million 3.1 million 1.8 million

CV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.8 million 1.5 million
Dec. 31, 2025 3.9 million 2.0 million
Sept. 30, 2025 3.5 million 1.6 million
June 30, 2025 3.3 million 1.5 million

CV

Price: $6.63

52 week price:
3.43
15.37

Earnings Per Share: -1.06 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 359.2 million

Links: